Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Exp Parasitol ; 122(3): 196-202, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19318094

RESUMO

We have selected piperaquine (PQ) and lumefantrine (LM) resistant Plasmodium berghei ANKA parasite lines in mice by drug pressure. Effective doses that reduce parasitaemia by 90% (ED(90)) of PQ and LM against the parent line were 3.52 and 3.93 mg/kg, respectively. After drug pressure (more than 27 passages), the selected parasite lines had PQ and LM resistance indexes (I(90)) [ED(90) of resistant line/ED(90) of parent line] of 68.86 and 63.55, respectively. After growing them in the absence of drug for 10 passages and cryo-preserving them at -80 degrees C for at least 2 months, the resistance phenotypes remained stable. Cross-resistance studies showed that the PQ-resistant line was highly resistant to LM, while the LM-resistant line remained sensitive to PQ. Thus, if the mechanism of resistance is similar in P. berghei and Plasmodium falciparum, the use of LM (as part of Coartem) should not select for PQ resistance.


Assuntos
Antimaláricos/farmacologia , Resistência a Medicamentos/fisiologia , Etanolaminas/farmacologia , Fluorenos/farmacologia , Plasmodium berghei/efeitos dos fármacos , Quinolinas/farmacologia , Amodiaquina/farmacologia , Amodiaquina/uso terapêutico , Animais , Antimaláricos/uso terapêutico , Artemisininas/farmacologia , Artemisininas/uso terapêutico , Cloroquina/farmacologia , Cloroquina/uso terapêutico , Modelos Animais de Doenças , Etanolaminas/uso terapêutico , Feminino , Fluorenos/uso terapêutico , Lumefantrina , Malária/tratamento farmacológico , Malária/parasitologia , Masculino , Camundongos , Parasitemia/tratamento farmacológico , Parasitemia/parasitologia , Quinolinas/uso terapêutico , Inoculações Seriadas/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA